Paul Alloway - Mar 25, 2024 Form 4 Insider Report for Q32 Bio Inc. (QTTB)

Role
Former President and Chief Operating Officer of Homology Medicines, Inc.
Signature
/s/ Paul Alloway
Stock symbol
QTTB
Transactions as of
Mar 25, 2024
Transactions value $
-$6,488
Form type
4
Date filed
4/23/2024, 05:03 PM
Previous filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QTTB Common Stock Sale -$6.49K -268 -9.36% $24.21* 2.6K Mar 25, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Paul Alloway is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of the RSUs.
F2 On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split.

Remarks:

Former President and Chief Operating Officer of Homology Medicines, Inc.